RUA Life Sciences PLC RUA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX29.50
- Day Range
- GBX29.75–30.85
- 52-Week Range
- GBX10.50–31.00
- Bid/Ask
- GBX29.00 / GBX31.00
- Shares Outstanding
- 62.06M
- Market Cap
- GBX1.85B
- Volume/Avg
- 75,409 / 162,024
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
RUA Life Sciences PLC is engaged in the contract design and manufacture of medical devices, exploiting the value of its IP and know-how, and developing cardiovascular devices. The Biomaterials segment is a licensor of Elast-Eon polymers to the medical device industry. The Medical Devices & Components segment is an end-to-end contract developer and manufacturer of medical devices and an implantable fabric specialist, which generates maximum revenue. The Vascular segment focuses on the development and commercialisation of the Group's Elast-Eon sealed Vascular Graft products. The Structural Heart segment focuses on the development of the Group's tri-leaflet polymeric heart valves. Geographically, it operates in Europe, North America, Middle East, Asia Pacific, and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 59
- Website
- https://www.rualifesciences.com
Valuation
|
Metric
|
RUA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.62 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
RUA
Financial Strength
|
Metric
|
RUA
|
|---|---|
Quick Ratio | 4.81 |
Current Ratio | 5.92 |
Interest Coverage | — |
Quick Ratio
RUA
Profitability
|
Metric
|
RUA
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
RUA
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|V&m&%#Q | LOCK|QDdwd | $172B | |||
| Medtronic PLC
MDT
| LOCK|<jJ<Vx | LOCK|?^xS | $113B | |||
| Stryker Corp
SYK
| LOCK|#^?Cqk@M | LOCK|g& | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|#fq!Q> | LOCK|b#<B | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|l>g?G!l | LOCK|^p@&! | $49B | |||
| DexCom Inc
DXCM
| LOCK|NF<@wTpm | LOCK|?r%& | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|^pzS?C? | LOCK|k% | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|&& | LOCK|#F> | $24B | |||
| Steris PLC
STE
| LOCK|G^pD>w | LOCK|<$MRK | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!wG?RTnX | LOCK|?m | $17B |
United States